- Newly established Focal Biosciences will focus on bringing together leading experts and scientific discoveries to harness cellular reprogramming in the fight against common age-related diseases
BOSTON & BERLIN & VILLIGEN, Switzerland--(BUSINESS WIRE)--Apollo Health Ventures and the Paul Scherrer Institute (PSI) launched Focal Biosciences. The newly established biotech company aims to redefine the treatment of age-related diseases by reprogramming deregulated cell states that drive the detrimental processes underlying many serious diseases of aging that represent a significant health burden.
Read More: BusinessWire - Jornalwebdigital
0 Comentários